116969 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Cysteine endopeptidases (3.4.22) Caspase-9 (3.4.22.62)
COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ADIPOSE TISSUE
#2IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#3SUSTAINED TRANSGENE EXPRESSION OF MODIFIED ERT2 PEPTIDE-SUICIDE PROTEIN FUSION POLYPEPTIDES
#4ANTI-PSMA SINGLE-CHAIN ANTIBODY, CHIMERIC ANTIGEN RECEPTOR ASSOCIATED THEREWITH AND USE THEREOF
#5ERT2 MUTANTS, INDUCIBLE CELL DEATH SYSTEMS, AND USES THEREOF
#6Safety Kill Switches for Engineered Cells Carrying Synthetic Chromosomes
#7MULTI-SWITCH RECEPTOR ARRAYS AND METHODS FOR IMPROVING IMMUNE CELL FUNCTION
#8PHAGOCYTOSIS ASSAY COMBINING A SYNTHETIC CELL DEATH SWITCH AND A PHAGOCYTOSIS REPORTER SYSTEM
#9CAS VARIANTS FOR GENE EDITING
#10SAFETY SWITCHES TO CONTROL IN VITRO AND IN VIVO PROLIFERATION OF CELL THERAPY PRODUCTS
#11GD2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#12IMMUNE CELL COMPOSITIONS AND METHODS OF USE
#13MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF
#14DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#15INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF
#16ENGINEERED CELLS FOR PRODUCING OF THERAPEUTIC AGENTS TO BE DELIVERED BY A HYBRID BIOELECTRONIC DEVICE
#17COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS
#18CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS
#19COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS
#20CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#21METHODS FOR INDUCING SELECTIVE APOPTOSIS
#22ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED CELLS
#23DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#24IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#25Modified caspase-9 polypeptides and methods of use thereof
#26DNA, EXPRESSION VECTOR, TRANSCRIPT, CELL, PHARMACEUTICAL COMPOSITION, AND MEDICINE
#27Method of screening inhibitor of caspase activity by lipopolysaccharide
#28METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
#29Cas variants for gene editing
#30Immune cell compositions and methods of use
#31FUSOGENIC LIPID NANOPARTICLES FOR THE TARGET CELL-SPECIFIC PRODUCTION OF RAPAMYCIN INDUCIBLE THERAPEUTIC PROTEINS
#32CR3022 chimeric antigen receptors and methods of use
#33T CELLS WITH SUICIDE SWITCH
#34ROBO1 CAR-NK CELL CARRYING SUICIDE GENE, PREPARATION METHOD AND APPLICATION THEREOF
#35COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
#36GD2-based chimeric antigen receptor and application thereof
#37INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF
#38CANCER VACCINE
#39LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#40SELECTION METHODS FOR GENETICALLY-MODIFIED T CELLS
#41ENGINEERED CELL DEATH-INDUCING ENZYMES AND METHODS OF USE
#42Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides
#43Chimeric protein
#44Immune cells expressing engineered antigen receptors
#45Compositions and methods for selective elimination and replacement of hematopoietic stem cells
#46METHODS FOR INDUCING SELECTIVE APOPTOSIS
#47Process for determining enzyme activity in a cell by activity-based reporter gene technology (ABRGT)
#48Cas variants for gene editing
#49T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
#50Compositions and methods for reducing tumor cell growth at a site of solid tumor excision
#51Chimeric antigen receptors and uses thereof
#52Modified caspase-9 polypeptides and methods of use thereof
#53Chimeric protein
#54Selection methods for genetically-modified T cells
#55Immune cell compositions and methods of use
#56METHODS FOR INDUCING SELECTIVE APOPTOSIS
#57MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF
#58Methods for inducing selective apoptosis
#59Chimeric protein
#60Compositions and methods for treating mesothelioma post-surgery
#61DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#62Modified Caspase polypeptides and uses thereof
#63Cas variants for gene editing
#64Cell-penetrating peptides
#65METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
#66T cell receptors directed against Bob1 and uses thereof
#67Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides
#68Methods for inducing selective apoptosis
#69CASPASE POLYPEPTIDES HAVING MODIFIED ACTIVITY AND USES THEREOF
#70Methods for nucleic acid editing
#71Fusions of Cas9 domains and nucleic acid-editing domains
#72Cell-penetrating peptides
#73Method for the determination of botulinum neurotoxin biological activity
#74Methods for inducing selective apoptosis
#75Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins
#76Genomic engineering of pluripotent cells